Global Cord Blood has acquired 2 companies, including 2 in the last 5 years.
Global Cord Blood’s largest acquisition to date was in 2022, when it acquired Cellenkos for $664M. Global Cord Blood has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
Join Mergr and gain access to Global Cord Blood’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2